Abnormalities of the spine. Disease of spinal cord, unspecified
Conditions
Interventions
Intervention 1: Intervention group: The first group includes 35 patients who will be infused with 0.2 micrograms/kg/minute of dexmedetomidine + 0.1 micrograms/kg/minute of Remifentanil + 0.5mg/kg/hour
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 20 to 60 years Patients with ASA CLASS 1 & 2 Patients who consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients with severe heart disease Patients with severe pulmonary and respiratory problems Patients with kidney failure, fever, infection, electrolyte disorder, acid-base disorder, allergy to the studied drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relaxation level. Timepoint: Before anesthesia, every 15 minutes until the end of surgery. Method of measurement: RAMSEY criterion.;Level of consciousness. Timepoint: Before anesthesia, every 15 minutes until the end of surgery. Method of measurement: bispectral index (BIS) criterion.;Vital signs. Timepoint: Before anesthesia, every 15 minutes until the end of surgery. Method of measurement: Vital signs monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh mohadaseh Azizanmortazavi
Ahvaz University of Medical Sciences
Outcome results
None listed